Kirkland & Ellis advised TPG Growth in its transaction and Manatt, Phelps & Phillips advised Sayari Labs, Inc.. TPG Growth (Nasdaq: TPG), TPG’s middle-market and growth...
TPG Growth’s $228 Million Investment in Sayari
Wilshire’s Acquisition of Lyxor Asset Management
Kirkland & Ellis and Solomon Partners are advising Wilshire on the transaction, and Clifford Chance and PJT Partners are advising Amundi S.A. Wilshire announced its acquisition...
Altaris’ Acquisition of Trean Insurance Group
Bass, Berry & Sims advised Trean Insurance Group, Inc. on the deal, while Kirkland & Ellis advised affiliates of Altaris. Trean Insurance Group, Inc. (Nasdaq: TIG),...
CPPIB’s $200 Million Investment in Redaptive
Wilson Sonsini Goodrich & Rosati advised Redaptive on the deal, while Kirkland & Ellis counseled Canada Pension Plan Investment Board. Energy-as-a-service provider Redaptive announced that it...
Kindeva Drug Delivery’s Combination With Meridian Medical Technologies
Kirkland & Ellis and ArentFox Schiff advised Altaris on the deal. Latham & Watkins represented the lenders on the financing aspects. Altaris, LLC, a healthcare investment...
Thoma Bravo’s Growth Investment in Circle Cardiovascular Imaging
Osler, Hoskin & Harcourt advised Circle CVI, while Kirkland & Ellis and McMillan advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm,...
Hyperfine and Liminal’s $580 Million Business Combination with HealthCor Catalio Acquisition Corp.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo and Conyers advised Hyperfine and Liminal Sciences on the deal, while Kirkland & Ellis counseled HealthCor Catalio Acquisition Corp....